A possible case of Etoricoxib- Induced Fixed Drug Eruption
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1
- 试验地点
- 1
- 主要终点
- Adverse drug reaction due to etoricoxib
研究概览
简要总结
A Case of Fixed Drug Eruption due to Etoricoxib in a 50yr old male patient
Dr Apoorva, Dr Girish K, Dr Namritha C Manjunath
Kempegowda Institute of Medical Sciences & Research Center (KIMS& RC), Bangalore,Karnataka,India
BACKGROUND/OBJECTIVES
Fixed drug eruption is a commonly reported adverse drug reaction.Non-steroidal anti inflammatory drugs(NSAIDs) in particular nimesulide are the most frequent agents, followed by antibiotics and anticonvulsants. Etoricoxib is a selective cyclo-oxygenase isoenzyme 2 inhibitor which has rarely been a cause of Fixed Drug Eruption.
We present a case of fixed drug eruption due to Etoricoxib in a 50yr old male patient with previous allergic history to NSAIDs.
CASE REPORT/METHODS:
50yr old male patient was prescribed Tab Etoricoxib by local doctor for low backpain.Next day the patient noticed reddish raised lesion, with pain and itching which was initially seen on the neck and gradually progressed to both the limbs and trunk. Subsequently, the patient was admitted to KIMS Hospital. A diagnosis of Fixed Drug Eruption due to Etoricoxib was made after ruling out other causes. Treatment was initiated with Intravenous and topical Steroids and IV Ceftriaxone was given for seconday infection. The lesions improved significantly with the above management and the patient was discharged after a week of admission.
RESULTS:
The reaction was assessed to be“probable†as per WHO-UMC and Naranjo causality scale, “moderateâ€on Hartwig’s scale and “Probably preventable†according to Schumock and Thornton criteria.
CONCLUSION:
Reactions such as Fixed Drug Eruptions can be caused by drugs like Etoricoxib.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50.00 Year(s) 至 51.00 Year(s)(—)
- 性别
- Male
入选标准
- •50 yr old male patient with complain of fixed drug eruption due to tab Etoricoxib.
排除标准
- 未提供
结局指标
主要结局
Adverse drug reaction due to etoricoxib
时间窗: within 24 hrs
次要结局
未报告次要终点
